Ophthalmic Surg Lasers Imaging Retina
October 2024
Background And Objective: This study aimed to report retinal displacement incidence following rhegmatogenous retinal detachment (RRD) repair with pars plana vitrectomy (PPV), scleral buckle (SB), or combined SB/PPV.
Patients And Methods: A single-center, case series using Optos fundus autofluorescence (FAF) images was performed after RRD repair between April 2020 and February 2022. Retinal displacement was identified by imprinted retinal vessels on FAF imaging.
To present 7 cases of West Nile virus (WNV)-related chorioretinitis in Arizona. Retina clinic charts with the terms "chorioretinitis" and "West Nile" were selected from April 1, 2012, to February 1, 2023. Seven patients with initial visits between August 2019 and February 2023 were included.
View Article and Find Full Text PDFPurpose Of Review: This review highlights the complications of both intravitreal injection procedure as well as different intravitreal medications including antivascular endothelial growth factors, antibiotics, antivirals, antifungals, methotrexate, and steroids. Techniques for reducing rates of endophthalmitis will also be discussed.
Recent Findings: Intravitreal vancomycin can cause hemorrhagic occlusive retinal vasculitis resulting in severe vision loss.
Background/aims: To evaluate the outcomes of eyes with macular oedema due to retinal vein occlusion (RVO) that are lost to follow-up (LTFU) after antivascular endothelial growth factor (VEGF) injections.
Method: A retrospective, single-centre, consecutive case series of RVO patients receiving injections who were LTFU >6 months was conducted. Data were collected from the visit before LTFU; return visit; 3 months, 6 months and 12 months after return; and the final visit.
Purpose: To evaluate the incidence of unexpected management changes on the first day after pars plana vitrectomy (PPV) for retinal detachment repair.
Design: Retrospective cohort study.
Methods: The medical and billing records of a large academic private practice were electronically queried for all cases of PPV for retinal detachment performed between January 1, 2017, and December 31, 2017.
Although intravitreal injections of anti-vascular endothelial growth factor medications are generally safe and effective, endophthalmitis remains a rare but potentially devastating complication. This review evaluates recent evidence for prophylactic strategies to prevent postinjection endophthalmitis. Povidone-iodine applied to the ocular surface before injection remains the most effective technique to prevent infection although aqueous chlorhexidine may be an acceptable alternative.
View Article and Find Full Text PDF